A detailed history of Beacon Capital Management, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Beacon Capital Management, LLC holds 673 shares of BSX stock, worth $56,895. This represents 0.01% of its overall portfolio holdings.

Number of Shares
673
Previous 576 16.84%
Holding current value
$56,895
Previous $39,000 30.77%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

BUY
$67.33 - $77.71 $6,531 - $7,537
97 Added 16.84%
673 $51,000
Q1 2024

May 16, 2024

BUY
$57.6 - $68.62 $32,889 - $39,182
571 Added 11420.0%
576 $39,000
Q1 2023

Apr 20, 2023

BUY
$45.09 - $50.03 $225 - $250
5 New
5 $0
Q1 2022

May 16, 2022

BUY
$40.9 - $45.1 $5,112 - $5,637
125 New
125 $6,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $121B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Beacon Capital Management, LLC Portfolio

Follow Beacon Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Capital Management, LLC with notifications on news.